How to Integrate Cancer Immunotherapy into Your Clinical Practice

June 1 from 11:00 AM-5:00 PM and June 2 from 7:30 AM-11:00 AM

Seminar Description

This seminar will enable clinical oncologists, nurses, pharmacists, and the entire medical team to effectively offer their patients additional treatment options through immunotherapy. After the seminar, attendees will be able to apply basic immunology principles to the clinical setting; effectively identify patients who might benefit from immunotherapy; confidently manage all aspects of patient care for those receiving immunotherapy; and describe emerging drugs and concepts in the field, including the value proposition of immunotherapy agents for patients and one’s clinical practice. This seminar will be co-sponsored with the Society for Immunotherapy of Cancer (SITC).

Seminar Committee

View Seminar Committee Disclosures

Mary L. (Nora) Disis, MD​ (Co-Chair)​
University of Washington

Mario Sznol, MD (Co-Chair)​
Yale School of Medicine

James L. Gulley, MD, PhD, FACP
National Cancer Institute

Lowell E. Schnipper, MD, FASCO
Beth Israel Deaconess Medical Center

Eleni Yeatras, RPh, BCOP
Sibley Memorial Hospital

Leisha Emens, MD, PhD
Johns Hopkins University

Doreen Higgins, RN, BSN, CCRP
University of Washington

Seminar Agenda

Day 1: Thursday, June 1, 2017: 12:30 PM – 5:00 PM

12:30 PM – 1:00 PM

Lunch

1:00 PM – 1:05 PM

Introduction

Mary L. (Nora) Disis, MD

1:05 PM – 2:55 PM

Session 1: The Immune System and Cancer

TBD – Chair

 

Justin Paul Kline, MD
Univeristy of Chicago
Basic Principles of Tumor Immunology for the Non-Immunologist

 

Brent Hanks, MD, PhD
Duke University Medical Center
Mechanisms of Immune Suppression

 

Sandra Demaria, MD
Weill Cornell Medical College
General Principles of Integrating and Sequencing Immune Therapy With Chemotherapy, Radiation Therapy, or Targeted Therapies

2:55 PM – 3:15 PM Break
3:15 PM – 5:00 PM

Session 2: Emerging Indications for Cancer Immunotherapy

Leisha Emens, MD, PhD – Chair
National Cancer Institute
Immunotherapy in Breast and Gyn Malignancies

 

Dung Le, MD
Sidney Kimmel Comprehensive Cancer Center
Immunotherapy in GI Malignancies

 

Tanguy Seiwert, MD
University of Chicago 
Immunotherapy for the Treatment of Head and Neck Cancers

 

Day 2: Friday, June 2, 2017: 7:00 AM – 11:00 AM

7:00 AM – 7:30 AM Breakfast

7:30 AM – 9:10 AM

Session 3: How to Integrate Immunotherapy into Clinical Practice

 

James Gulley, MD, PhD, FACP – Chair
National Cancer Institute

 

Jeffrey Weber, MD, PhD
NYU Langone Medical Center
Immunotherapy for Melanoma

 

Naiyer Rizvi, MD
Columbia University
Immunotherapy for the Treatment of non-small Cell Lung Cancer

 

Arjun Balar, MD
NYU Langone Medical Center
Immunotherapy for the Treatment of GU Cancers

 

Stephen M. Ansell, MD, PhD
Mayo Clinic Cancer Center
Immune Checkpoint and Cell Therapies for Hematologic Malignancies

 
9:10 AM – 9:25 AM Break
9:25 AM – 11:00 AM

Session 4: How to Integrate Immunotherapy Into Clinical Practice

 

Mario Sznol, MD – Chair
Yale School of Medicine and Yale Cancer Center
Management of Adverse Events

 

Brianna Hoffner, NP
University of Colorado Denver
Nursing Aspects in the Clinical Management of Patients Receiving Immunotherapy

 

Lowell E. Schnipper, MD, FASCO
Beth Israel Deaconess Medical Center
What Is the Value of Immunotherapy in Contemporary Oncology Practice?

 

Patrick Hwu, MD
MD Anderson Cancer Center
What Are the Most Promising New Immunotherapy Strategies?